University of Pennsylvania, Philadelphia, PA19104, USA.
Pain Med. 2010 Dec;11(12):1765-73. doi: 10.1111/j.1526-4637.2010.00943.x. Epub 2010 Aug 31.
The primary aim was to evaluate the prevalence of inadvertent intradiscal injection during fluoroscopically guided contrast-enhanced lumbar transforaminal epidural steroid injections. The secondary aim was to determine if there are any risk factors for or adverse events as a result of inadvertent intradiscal contrast injection.
The study was a retrospective case series.
The study was set in three outpatient spine care centers.
A search was conducted in a database of spinal injection procedures from July 2000-May 2008. Fifteen cases of inadvertent intradiscal contrast flow were identified. These cases were matched with one control case with the same age, gender, level, and side of injection.
The prevalence of intradiscal contrast flow with lumbar transforaminal epidural steroid injection was calculated. Chart review of the cases and controls was performed. An independent, blinded examiner evaluated needle tip placement.
Frequency of intradiscal contrast flow during lumbar transforaminal epidural steroid injections and the relationship between the occurrence of intradiscal contrast flow with potential risk factors.
The prevalence of inadvertent intradiscal injection during lumbar transforaminal epidural steroid injections was 0.17%. All of the patients received prophylactic antibiotics after inadvertent disk injection, and there were no infectious or other complications identified.
Intradiscal contrast injection is an infrequently reported event during lumbar transforaminal epidural steroid injections. Our data support that the prevalence is very low and there might be an association with ipsilateral foraminal stenosis. Although there is potential for significant adverse complications with intradiscal injection, our data set did not show serious sequelae.
本研究旨在评估在透视引导下经椎间孔腰椎硬膜外类固醇注射时意外椎间盘内注射的发生率。次要目的是确定是否存在任何与意外椎间盘内对比剂注射相关的风险因素或不良事件。
本研究为回顾性病例系列研究。
本研究在三个门诊脊柱治疗中心进行。
2000 年 7 月至 2008 年 5 月,对脊柱注射程序数据库进行了搜索,共发现 15 例意外椎间盘内对比剂流动的病例。这些病例与同一年龄、性别、注射水平和侧别的对照病例相匹配。
计算腰椎经椎间孔硬膜外类固醇注射时椎间盘内对比剂流动的发生率。对病例和对照组的图表进行了回顾。一位独立的、盲法评估员评估了针尖的位置。
腰椎经椎间孔硬膜外类固醇注射时椎间盘内对比剂流动的频率,以及椎间盘内对比剂流动的发生与潜在风险因素之间的关系。
腰椎经椎间孔硬膜外类固醇注射时意外椎间盘内注射的发生率为 0.17%。所有患者在意外椎间盘注射后均接受了预防性抗生素治疗,未发现感染或其他并发症。
椎间盘内对比剂注射在腰椎经椎间孔硬膜外类固醇注射中是一种罕见的报道事件。我们的数据支持这种发生率非常低,并且可能与同侧椎间孔狭窄有关。尽管椎间盘内注射有发生严重不良并发症的潜在风险,但我们的数据组并未显示出严重的后遗症。